Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Prothena Corp Public (PRTA) over the last 14 years, with Q3 2025 value amounting to $7.2 million.

  • Prothena Corp Public's Share-based Compensation fell 3467.33% to $7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.1 million, marking a year-over-year decrease of 1168.86%. This contributed to the annual value of $46.0 million for FY2024, which is 1234.3% up from last year.
  • Prothena Corp Public's Share-based Compensation amounted to $7.2 million in Q3 2025, which was down 3467.33% from $12.4 million recorded in Q2 2025.
  • Prothena Corp Public's 5-year Share-based Compensation high stood at $12.4 million for Q2 2025, and its period low was $6.1 million during Q3 2021.
  • Over the past 5 years, Prothena Corp Public's median Share-based Compensation value was $10.1 million (recorded in 2023), while the average stood at $9.5 million.
  • In the last 5 years, Prothena Corp Public's Share-based Compensation surged by 4906.5% in 2023 and then crashed by 3467.33% in 2025.
  • Over the past 5 years, Prothena Corp Public's Share-based Compensation (Quarter) stood at $6.9 million in 2021, then increased by 7.93% to $7.4 million in 2022, then surged by 49.06% to $11.1 million in 2023, then fell by 5.05% to $10.5 million in 2024, then tumbled by 31.57% to $7.2 million in 2025.
  • Its Share-based Compensation stands at $7.2 million for Q3 2025, versus $12.4 million for Q2 2025 and $10.9 million for Q1 2025.